Soluble immune complexes bind to unprimed neutrophils and generate intracellular Ca
2؉ transients but fail to activate the NADPH oxidase. Following priming of the neutrophils with either tumor necrosis factor ␣ or granulocyte-macrophage colony-stimulating factor, stimulation of the cells with the soluble immune complexes leads to an enhanced Ca 2؉ signal and significant secretion of reactive oxidants. The enhanced Ca 2؉ signal observed in primed neutrophils results from the influx of Ca 2؉ from the external environment and is partly sensitive to tyrosine kinase inhibitors. This is in contrast to the Ca 2؉ signal observed in unprimed neutrophils, which arises from the mobilization of intracellular stores. When the surface expression of Fc␥RIIIb on primed neutrophils was decreased either through incubation with Pronase or phosphoinositide-specific phospholipase C, the extra enhanced Ca 2؉ mobilization seen in primed cells was significantly lowered, while the initial rise in intracellular Ca 2؉ was unaffected. Depletion of Fc␥RIIIb had no significant effect on the Ca 2؉ transients in unprimed neutrophils. Cross-linking Fc␥RII, but not Fc␥RIIIb, induced increases in intracellular Ca 2؉ in unprimed neutrophils, while cross-linking either of these receptors increased Ca 2؉ levels in primed neutrophils. The Fc␥RII-dependent intracellular Ca Neutrophils play a major role in host defense via the phagocytosis and destruction of pathogens during acute inflammation. The binding of opsonized bacteria or immune complexes to neutrophil immunoglobulin receptors (Fc␥R) can activate a number of processes such as phagocytosis, degranulation and activation of the NADPH oxidase (1, 2) . However, in addition to this protective role, inappropriate activation of neutrophils to release oxygen metabolites and granule enzymes within tissues can result in tissue damage in inflammatory conditions such as rheumatoid arthritis (1, 2) . Furthermore, immune complex deposition followed by subsequent neutrophil activation is important in the pathogenesis of serum sickness, the Arthus reaction, acute glomerulonephritis, and other idiopathic inflammatory diseases (3, 4) . Neutrophils are activated within the synovial joints of rheumatoid patients (5-10), and we have shown that synovial fluid from patients with rheumatoid arthritis contains both soluble and insoluble IgG-containing immune complexes, which are capable of activating neutrophils (11) (12) (13) . However, the soluble immune complexes only activate neutrophils that have been previously primed in vivo or in vitro by GM-CSF 1 or ␥-interferon and this activation leads to the secretion of reactive oxidants and granule enzymes (11) (12) (13) . In contrast, insoluble immune complexes activate both primed and unprimed neutrophils with nearly equal efficacy but the oxidants generated are largely retained intracellularly, i.e. within phagolysosomes. Thus, soluble immune complexes may be of greater importance than insoluble complexes in the destructive processes that occur during inflammatory diseases because they activate the secretion of large quantities of cytotoxic products. The identification of the molecular processes that occur during neutrophil priming to allow activation of oxidant secretion in response to soluble complexes may therefore be of value in identifying new targets for therapeutic intervention.
IgG-containing immune complexes stimulate neutrophils via Fc␥ receptors, two types of which are expressed on freshly isolated control blood cells (14) . Fc␥RII (CD32) is a 40-kDa transmembrane-spanning molecule with a cytoplasmic tail that allows its interaction with G-proteins, whereas Fc␥RIIIb is a heavily glycosylated molecule of 50 -70 kDa, linked to the membrane via a glycosylphosphatidylinositol anchor (15) . Thus, although Fc␥RIIIb has the potential for rapid lateral mobility within the membrane, it is unable to couple directly to either G-proteins or to the cytoskeleton, and it is unclear how ligation to this receptor might lead to the transduction of intracellular signals. Expression of Fc␥RIIIb on the plasma membrane (100,000 -200,000 molecules/cell) is approximately 10 -15-fold greater than the expression of Fc␥RII (7000 -15,000 molecules/cell).
There is much debate as to the independent and co-operative roles of Fc␥RII and Fc␥RIIIb in neutrophil activation. Neither receptor binds monomeric IgG, but they bind dimers, trimers, immune complexes, and opsonized particles (16, 17) . Although reports in the literature are conflicting, it is currently thought that occupancy of Fc␥RII leads to activation of reactive oxidant production, degranulation, and phagocytosis (18 -22 (33) , and the method used to isolate neutrophils may influence the results obtained because some separation procedures may result in inadvertent priming of the neutrophil (34, 35) .
In this study, we have investigated Ca 2ϩ mobilization in neutrophils stimulated with soluble immune complexes in both primed and unprimed neutrophils. We present evidence that the initial cytosolic Ca 2ϩ increase observed following stimulation with soluble complexes is the result of ligation of Fc␥RII and that this interaction is insufficient to activate the respiratory burst. When soluble complexes are added to primed neutrophils oxidant secretion is initiated and an enhanced mobilization of Ca 2ϩ results, mainly via influx from extracellular sources. It would appear that this extra intracellular Ca 2ϩ signal results from functional activation of Fc␥RIIIb during priming. These studies add new insights into the mechanisms by which cellular priming alters the functional responsiveness of neutrophils during inflammatory activation.
EXPERIMENTAL PROCEDURES
Materials-Neutrophil isolation medium was from Cardinal Associates Inc., RPMI 1640 medium from Flow Laboratories; Fluo-3-AM, erbstatin, and genistein were from Calbiochem. rGM-CSF was a nonglycosylated peptide from Glaxo and had an activity of Ն1.5 milliunits/mg of protein in the AML-193 proliferation assay. TNF␣ was from National Institute for Biological Standards and Controls, Potters Bar, United Kingdom. F(abЈ) 2 fragments of monoclonal antibody 3G8 (recognizing Fc␥RIIIb) and Fab fragments of IV.3 (recognizing Fc␥RII) were from Medarex, Inc. PI-PLC was from Boehringer Mannheim. All other specialist reagents were from Sigma.
Neutrophil Isolation-Neutrophils were isolated from the venous blood of healthy volunteers by centrifugation on neutrophil isolation medium for 15 min at 400 ϫ g (36) . After removal of contaminating erythrocytes by hypotonic lysis, purified neutrophils were suspended in RPMI 1640 medium and counted. Neutrophil purity (assessed by Wright's staining) and viability (assessed by trypan blue exclusion) were Ͼ97% and Ͼ95%, respectively.
Neutrophil Priming-Neutrophils were primed using either GM-CSF or TNF␣. Cells (10 7 /ml) were incubated in the presence and absence of GM-CSF (50 units/ml) for 1 h at 37°C, whereas TNF␣ (50 ng/ml) was added 10 min prior to stimulation.
Immune Complex Preparation-Synthetic immune complexes were made from human serum albumin and rabbit anti-human serum albumin antibodies as described previously (37) . The antigen was titrated against constant antibody concentration and the A 450 nm measured to identify equivalence. The soluble complexes were formed at 6 ϫ antigen equivalence and were briefly centrifuged (2 min at 13,000 ϫ g in a microcentrifuge) to remove any contaminating insoluble immune complexes that may have been present. Soluble complexes were formed at 180 g/ml antigen and 125 g/ml antibody. A 10% (v/v) solution of complexes was used routinely for neutrophil stimulation.
Reactive Oxidant Production-Chemiluminescence was measured at 37°C in neutrophil suspensions (5 ϫ 10 5 /ml) in RPMI 1640 medium that was supplemented with 10 M Luminol using an LKB 1251 luminometer (38, 39) . For measurements of superoxide secretion, neutrophils were suspended in RPMI 1640 supplemented with 75 M cytochrome c (40) . Absorption changes were recorded at 550 nm using a Bio-Rad 3550 kinetic plate reader. Reference wells contained 30 g/ml superoxide dismutase.
Intracellular Receptor Cross-linking and mAb Blocking Studies-For measurements of intracellular Ca 2ϩ following the cross-linking of receptors, Fluo-3-loaded neutrophils (2 ϫ 10 6 /ml) were incubated with 1 g/ml Fab/F(abЈ) 2 fragments of appropriate monoclonal antibodies at 37°C prior to cross-linking with 40 g/ml F(abЈ) 2 fragments of goat antimouse IgG. For mAb blocking studies, 3 ϫ 10 6 neutrophils were incubated with 3 g of Fab/F(abЈ) 2 fragments in a volume of 250 l for 10 min at 37°C prior to dilution (to 5 ϫ 10 5 cells/ml) and stimulation of cells with soluble immune complexes.
Inositol 1,4,5-Trisphosphate Assays-Neutrophils were incubated for 45 min in the presence (primed) and absence (control) of 50 units/ml GM-CSF. Fc␥RII and Fc␥RIIIb were then cross-linked (as described above), and samples were removed at time intervals. IP 3 was then extracted by rapidly mixing samples with 0.2 volume of ice-cold 20% (v/v) perchloric acid. After neutralizing extracts, IP 3 was quantified using a competitive binding assay (Amersham, UK) using D-myo-inositol 1,4,5-trisphosphate as a calibration standard.
RESULTS

Reactive Oxidant Generation Induced by Soluble Immune
Complexes-Addition of synthetic soluble IgG immune complexes to freshly isolated neutrophils failed to activate reactive oxidant generation ( Fig. 1) , as detected by Luminol chemiluminescence. However, if the cells were primed by prior addition of GM-CSF (50 units/ml for 1 h) or TNF␣ (50 ng/ml for 10 min), then the soluble complexes activated a rapid and transient burst of oxidase activity that peaked 2-3 min after addition (Fig. 1, A and C) . Luminol-dependent chemiluminescence detects both intra-and extracellular oxidant production (39) , but the use of cytochrome c, which is a large basic molecule that cannot permeate the cell, specifically measures O 2 . secretion (38) . (Fig. 2) . This increase in intracellular Ca 2ϩ was comparable to that induced by addition of 0.1 M fMet-Leu-Phe (data not shown). When the neutrophils were primed by exposure to TNF␣ prior to stimulation with the soluble complexes, there was again a rapid rise in intracellular Ca 2ϩ levels ( Fig. 2A) , but the kinetics of the increase were altered. The initial increase in intracellular Ca 2ϩ seen in unprimed neutrophils was unaffected, but this was followed by a second, more sustained increase in intracellular Ca 2ϩ . Similarly, when the neutrophils were primed with GM-CSF (Fig.  2B) , the intracellular Ca 2ϩ mobilization induced by the soluble immune complexes was enhanced and prolonged in comparison to that observed in unprimed cells. Increasing the concentrations of soluble immune complexes (to 20% and 30%, v/v) did not change either the kinetics or the magnitude of the intracellular Ca 2ϩ transients seen in unprimed cells. Thus, priming does not affect the affinity of binding of soluble immune complexes under these conditions.
Effect of EGTA on Intracellular Ca 2ϩ Mobilization-To determine the source of the increased intracellular Ca 2ϩ levels in both unprimed and primed neutrophils, incubations in Ca 2ϩ -free medium in the presence of 1 mM EGTA were performed. -containing buffer. Thus, in unprimed neutrophils, the observed increases in intracellular Ca 2ϩ arise from the mobilization of intracellular stores. In contrast, when primed cells were stimulated with soluble immune complexes Ca 2ϩ -free buffer, the initial intracellular Ca 2ϩ increase was unaffected, but the extended "extra" Ca 2ϩ signal only seen in primed cells, was not observed (Fig. 3 , B and C). These experiments thus indicate that the enhanced and prolonged increase in intracellular Ca 2ϩ observed only in primed cells is due to Ca 2ϩ influx from external sources.
Role of Tyrosine Kinases in Ca
2ϩ Mobilization-When unprimed neutrophils were incubated with the tyrosine kinase inhibitor, erbstatin (1 g/ml), the intracellular Ca 2ϩ response obtained following stimulation with the soluble complexes was inhibited by 30% (Ϯ 8%, n ϭ 6). When neutrophils were primed with either TNF␣ (Fig. 4B) or GM-CSF (Fig. 4C) , the enhanced intracellular Ca 2ϩ signal seen only in primed neutrophils was similarly decreased. This concentration of erbstatin decreased reactive oxidant generation stimulated by soluble immune complexes in primed neutrophils by Ͼ95% (data not shown). Similar results were obtained following addition of another tyrosine kinase inhibitor genistein at 100 M (data not shown). Addition of erbstatin at 2 g/ml inhibited the unprimed Ca 2ϩ signal by over 50%, but did not result in greater inhibition of the primed response (data not shown).
To determine whether erbstatin exhibited nonspecific toxic effects at these concentrations, the experiments shown in Fig.  5 were performed. After addition of soluble immune complexes to primed neutrophils incubated in the presence and absence of erbstatin, fMet-Leu-Phe was added. The intracellular Ca 2ϩ transients stimulated by fMet-Leu-Phe were unaffected by the inhibitor; this fMet-Leu-Phe-induced response was identical to that observed following its addition to suspensions that had not previously been stimulated by immune complexes.
Role of Fc␥ Receptors: Depletion of Surface Receptors-When neutrophils were incubated with PI-PLC (at 0.25 units/ml for 30 min), the surface expression of Fc␥RIIIb, which is glycosylphosphatidylinositol-linked (14, 15) , detected by fluorescent-activated cell sorting was decreased to levels that were indistinguishable from nonspecific antibody binding (Fig. 6A, i) . This treatment had no effect on the expression of Fc␥RII (Fig. 6A, ii) or on the expression of CD11b (data not shown). Similarly, incubation with Pronase (0.05 mg/ml for 30 min) also resulted in the decreased surface expression of Fc␥RIIIb but had no effect on expression of Fc␥RII or CD11b (data not shown).
When Fc␥RIIIb expression on the surface of primed neutrophils was depleted by treatment with either Pronase or PI-PLC, the soluble immune complexes failed to activate the respiratory burst (Fig. 6, inset) . Neutrophils treated in this way can, however, still generate reactive oxidants in response to large, insoluble immune complexes or PMA (13) .
When unprimed neutrophils were depleted of surface Fc␥RIIIb by treatment with PI-PLC, there was very little effect on the intracellular Ca 2ϩ rise stimulated by soluble immune complexes (Fig. 6B, i) . This result indicates that expression of Fc␥RIIIb is not required for the transient, intracellular Ca 2ϩ increase that arises from the mobilization of intracellular stores following the binding of soluble immune complexes to the surface of unprimed cells. However, in primed cells, Pronase treatment had a marked effect on the intracellular Ca 2ϩ signals (Fig. 6B, ii) . In primed cells depleted of Fc␥RIIIb, the initial intracellular Ca 2ϩ transient was unaffected, but the later, sustained intracellular Ca 2ϩ signal that arises from Ca 2ϩ influx was not observed. Similar results were obtained when the neutrophils were primed with TNF␣ and when Fc␥RIIIb was depleted from the cell surface by incubation with Pronase (data not shown). These data thus indicate distinct roles for individual Fc␥R in the control of these intracellular Ca 2ϩ signals in primed and unprimed neutrophils. Thus, the initial intracellular Ca 2ϩ transient that is seen in both unprimed and primed neutrophils appears to be due to signals generated via occupancy of Fc␥RII; this intracellular Ca 2ϩ signal arises from the mobilization of intracellular stores. In contrast, the extra intracellular Ca 2ϩ signal that is only seen in primed cells requires Fc␥RIIIb and arises from Ca 2ϩ influx. fragments, resulted in a monophasic increase in intracellular Ca 2ϩ (Fig. 7A ). The kinetics of this intracellular Ca 2ϩ increase were unaltered when the cells were primed with either GM-CSF (Fig. 7A ) or TNF␣ (data not shown), but a greater intracellular Ca 2ϩ transient was observed in primed cells. The kinetics of these increases in intracellular Ca 2ϩ resemble those observed during incubation of unprimed neutrophils with soluble immune complexes (Fig. 2) . However, when unprimed neutrophils were incubated with F(abЈ) 2 fragments of 3G8 (anti-Fc␥RIIIb) prior to cross-linking, no increases in intracellular Ca 2ϩ were observed (Fig. 7B) . Thus, ligation of Fc␥RIIIb in unprimed neutrophils fails to generate increases in intracellular Ca 2ϩ . However, if the cells were primed with either GM-CSF (Fig. 7B) -free medium (containing 1 mM EGTA) (Fig. 8A) . This result indicates that the Ca 2ϩ signal generated following ligation of this receptor arises largely from the mobilization of intracellular stores. In complete contrast, the Fc␥RIIIb-dependent intracellular Ca 2ϩ signal was greatly decreased when the cells were suspended in Ca 2ϩ -free medium (Fig. 8B) , indicating that Ca 2ϩ influx is largely responsible for the intracellular Ca 2ϩ signal following ligation of this receptor.
Role of Fc␥R Ligation of Individual Receptors-To
The Fab/F(abЈ) 2 fragments were then used to confirm the roles of these Fc␥Rs in the generation of intracellular Ca 2ϩ signals in response to soluble immune complexes. Addition of 3G8 F(abЈ) 2 fragments (anti-Fc␥RIIIb) prior to the addition of soluble immune complexes had no effect on the intracellular Ca 2ϩ transients generated in unprimed cells (Fig. 9A) , but significantly decreased the extra Ca 2ϩ signal observed in primed cells (Fig. 9B) . However, addition of IV3 Fab fragments (anti-Fc␥RII) prior to the addition of soluble immune complexes inconsistently affected the intracellular Ca 2ϩ transients. It may be that mAb IV3 is readily displaced from Fc␥RII by the soluble immune complexes. These experiments, however, confirm a role for Fc␥RIIIb in the extra intracellular signal seen in primed cells.
IP 3 Production following Neutrophil Activation-Stimulation of neutrophils with fMet-Leu-Phe resulted in a rapid and transient elevation in the levels of IP 3 (Fig. 10A) , which peaked within 10 -15 s and then declined. However, ligation of either Fc␥RII (Fig. 10B) or Fc␥RIIIb (Fig. 10C) failed to activate the production of significant levels of IP 3 in either primed or unprimed cells.
DISCUSSION
In this study we have investigated the mechanisms by which soluble immune complexes activate neutrophils via Fc␥ receptors. Defining this interaction is important because several immune conditions are associated with neutrophil activation via immune complexes (1-3) . These soluble immune complexes fail to activate the respiratory burst when added to suspensions of unprimed cells. However, if the cells are primed (as in our study using the cytokines GM-CSF and TNF␣), then soluble immune complex binding results in the secretion of large quantities of reactive oxygen metabolites. Because neutrophil function in vivo is invariably regulated by exposure to priming agents and because these soluble immune complexes activate the secretion of potentially tissue-damaging components, these results are important in understanding the molecular pathology of certain neutrophil-mediated conditions. In our study, we have used a neutrophil isolation procedure that induces minimal priming during cell isolation. Many commonly used isolation methods (33, 34, 42) , however, inadvertently prime both receptor number/function and NADPH oxidase activity and hence experiments with cells isolated by such methods cannot clearly distinguish between neutrophil responses that are restricted to either the primed or the unprimed state.
Whereas the soluble immune complexes failed to activate the NADPH oxidase in unprimed cells, the use of fluorescein isothiocyanate-labeled complexes showed that they clearly bind to the cell surface (data not shown). These fluorescein isothiocyanate-labeled complexes activated neutrophils in identical ways to the unlabeled complexes, indicating that their molecular properties were unaltered during the labeling process. We have previously shown that the synthetic soluble immune complexes used in these studies and those isolated from rheumatoid synovial fluid, activate primed and unprimed neutrophils by analogous mechanisms (12, 43) . The fact that these complexes activated increases in intracellular Ca 2ϩ in unprimed cells is indicative that they bind to functionally active receptors on the cell surface. Hence, we conclude that the key event that occurs during priming that allows the primed cell to generate reactive oxidants in response to soluble immune complexes is not increased complex binding. Indeed, priming results in only small changes in the level of expression of either Fc␥RII or Fc␥RIIIb, whereas surface expression of CR3 is greatly up-regulated (44). We thus searched for events downstream of receptor/ligand binding that may account for the altered functional responses of primed cells.
In unprimed cells, the soluble immune complexes activated a transient increase in intracellular Ca 2ϩ that was due to mobilization of intracellular stores and was partly sensitive to inhibition with tyrosine kinase inhibitors. Several other reports have shown that, while intracellular Ca 2ϩ transients are necessary for NADPH oxidase activation, they are in themselves not sufficient to induce activation (45, 46) . When the cells were primed, however, an extra intracellular Ca 2ϩ transient was generated. This arose from influx of Ca 2ϩ from external sources and was also partly sensitive to inhibition by tyrosine kinase inhibitors. These data indicate that this extra intracellular Ca 2ϩ signal may be due to signals generated via receptors that become "activated" during the priming process. We thus set out to identify these putative receptors.
Circulating blood neutrophils possess two types of receptors that recognize IgG-containing immune complexes, namely Fc␥RII and Fc␥RIIIb (14) . Fc␥RIIIb is linked to the plasma membrane via a glycosylphosphatidylinositol linkage that can be easily cleaved either in vivo or in vitro with Pronase or PI-PLC (15, 17) . Our first experiments thus used Pronase and PI-PLC to deplete the cell surface of Fc␥RIIIb while not affecting expression of Fc␥RII. Fc␥RIIIb-depleted (unprimed) neutrophils could generate intracellular Ca 2ϩ transients in response to soluble immune complexes, and the kinetics of these transients were identical with those observed in untreated (Fc␥RIIIb-expressing) cells. However, the extra intracellular Ca 2ϩ signal normally observed during priming was not observed after Fc␥RIIIb depletion. Furthermore, this extra intracellular Ca 2ϩ signal was not observed when primed cells were incubated F(abЈ) 2 (31, 32) . There are numerous reports in the literature regarding the interaction of immune complexes with neutrophil Fc receptors, but none have addressed the interaction of soluble complexes with primed and unprimed cells. In our experiments, the intracellular Ca 2ϩ transients generated by Fc␥RII ligation were partly sensitive to inhibition with tyrosine kinase inhibitors, confirming the recently reported association of Fc␥RII with tyrosine kinase activity (23, 24, 26, 27) . Our data also confirm the importance of tyrosine kinase activity and Fc␥RIIIb function (27) , and we propose that tyrosine kinase activity becomes associated with Fc␥RIIIb during priming and regulates Ca 2ϩ influx. We speculate that during priming a Src-like tyrosine kinase (perhaps Hck; Ref. 27) becomes associated with Fc␥RIIIb. This could then result in the assembly of a new signaling cassette linking Fc␥RIIIb ligation to cell activation. Several reports have shown that Fc␥RIIIb can transduce signals, including intracellular Ca 2ϩ transients independently of Fc␥RII (28 -30) . A synergistic response of Fc␥RIIIb and CR3 has previously been reported, whereby CR3 immobilizes Fc␥RII to the plasma membrane via a cytoskeletal-dependent mechanism and then ligation of Fc␥RIIIb induces tyrosine activation in the proximity of Fc␥RII (25) . In our experiments using synthetic soluble immune complexes, anti-CR3 antibodies do not affect the ability of primed neutrophils to activate a respiratory burst. Thus, the dependence of the response on CR3 may be diminished in primed neutrophils.
These studies shed new insights into the mechanisms by which soluble immune complexes activate neutrophils in pathological conditions that may result in tissue damage. There is much interest in the pharmacological down-regulation of neutrophil function in inflammatory conditions, but any therapy designed to interfere with neutrophil-mediated responses must be selective; such therapy must specifically block the harmful consequences of neutrophil activation that lead to tissue damage (e.g. result in secretion of cytotoxic products) but not compromise opsono-phagocytosis and host defense against infections. It is interesting to note that individuals with Fc␥RIIIb deficiency are often asymptomatic and do not generally suffer recurrent infections (47, 48) . Therefore, we predict that neutrophils from these individuals will not be able to secrete reactive oxygen metabolites in response to soluble immune complexes, and thus it will be necessary to test this hypothesis using neutrophils from these individuals. If correct, then our data offer the possibility that selective inhibition of the signaling pathway from Fc␥RIIIb/soluble immune complex ligation to activation of the NADPH oxidase could provide the basis for a novel therapeutic strategy for the treatment of immune disorders involving soluble immune complexes and primed neutrophils. FIG. 10 . Changes in IP 3 levels during neutrophil activation by fMet-Leu-Phe and Fc␥Rs. In A, neutrophils were incubated in the presence (q) or absence (E) of 0.1 M fMet-Leu-Phe, and at time intervals samples were removed for the analysis of IP 3 , as described under "Experimental Procedures." In B and C, neutrophils were incubated in the presence (E) and absence (q) of 50 units/ml GM-CSF for 45 min prior to cross-linking either Fc␥RII (B) or Fc␥RIIIb (C), as described ''Experimental Procedures.'' Values are means (Ϯ S.D. of triplicate measurements). Similar results were obtained in three separate experiments using different preparations of neutrophils.
